The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lindahl Richard S since 2010.
This trader's CIK number is 1196632.
At the time of last reporting, Lindahl Richard S was the EVP, Chief Financial Officer of Emergent Biosolutions Inc.. (stock ticker symbol EBS).
Also see all insider trading activities at Emergent Biosolutions Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | CEB | 0 | $0 | 0 | $0 | 15,949 | $0 |
2016 | CEB | 0 | $0 | 0 | $0 | 8,397 | $0 |
2015 | CEB | 0 | $0 | 0 | $0 | 13,959 | $0 |
2014 | CEB | 0 | $0 | 15,000 | $926,337 | 9,113 | $0 |
2013 | CEB | 0 | $0 | 0 | $0 | 10,583 | $0 |
2012 | CEB | 1,000 | $41,500 | 0 | $0 | 8,195 | $0 |
2011 | CEB | 0 | $0 | 0 | $0 | 5,637 | $0 |
2010 | CEB | 0 | $0 | 0 | $0 | 3,678 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | EBS | 3,000 | $112,380 | 0 | $0 | 0 | $0 |
1. Corporate Executive Board Co (CEB)
2. Emergent Biosolutions Inc. (EBS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-04-05 | CEB | Option Ex | 7,686 | .00 | 0 |
2017-03-27 | CEB | Option Ex | 6,008 | .00 | 0 |
2017-02-17 | CEB | Option Ex | 2,255 | .00 | 0 |
2016-04-25 | CEB | Option Ex | 2,052 | .00 | 0 |
2016-03-28 | CEB | Option Ex | 6,345 | .00 | 0 |
2015-04-27 | CEB | Option Ex | 1,750 | .00 | 0 |
2015-03-27 | CEB | Option Ex | 2,208 | .00 | 0 |
2015-03-30 | CEB | Option Ex | 4,945 | .00 | 0 |
2015-02-20 | CEB | Option Ex | 5,056 | .00 | 0 |
2014-08-01 | CEB | Sale | 6,300 | 61.75 | 389,025 |
2014-07-31 | CEB | Sale | 8,700 | 61.76 | 537,312 |
2014-04-28 | CEB | Option Ex | 2,209 | .00 | 0 |
2014-03-28 | CEB | Option Ex | 2,388 | .00 | 0 |
2014-03-31 | CEB | Option Ex | 4,516 | .00 | 0 |
2013-06-10 | CEB | Option Ex | 3,677 | .00 | 0 |
2013-04-29 | CEB | Option Ex | 2,389 | .00 | 0 |
2013-04-01 | CEB | Option Ex | 4,517 | .00 | 0 |
2012-11-20 | EXBD | Buy | 1,000 | 41.50 | 41,500 |
2012-06-11 | EXBD | Option Ex | 3,678 | .00 | 0 |
2012-04-30 | EXBD | Option Ex | 2,558 | .00 | 0 |
2012-04-02 | EXBD | Option Ex | 1,959 | .00 | 0 |
2011-06-10 | EXBD | Option Ex | 3,678 | .00 | 0 |
2011-05-01 | EXBD | Option Ex | 1,959 | .00 | 0 |
2010-07-12 | EXBD | Option Ex | 3,678 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-11-15 | EBS | Buy | 3,000 | 37.46 | 112,380 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lindahl Richard S (EVP, Chief Financial Officer of Emergent Biosolutions Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.